Начало › Рак на белия дроб с недребноклетъчен тип › Илинойс › Peoria
Клинични проучвания за Рак на белия дроб с недребноклетъчен тип в Peoria, IL
21 проучвания за Рак на белия дроб с недребноклетъчен тип търсят участници в обекти в и около Peoria (в радиус от около 30 мили). Отворете проучването, за да видите кой може да участва и как да се свържете с екипа.
Официален текст на проучването (английски)
Търсите участници за проучване? Представяме го в началото на тази страница — $99 за 30 дни →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Набиране на участнициФаза 3
- Illinois CancerCare-Peoria, Peoria
- Illinois CancerCare-Pekin, Pekin · на 9 мили
- Illinois CancerCare-Canton, Canton · на 25 мили
A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment
Набиране на участнициФаза 2
- Illinois CancerCare-Peoria, Peoria
- OSF Saint Francis Radiation Oncology at Peoria Cancer Center, Peoria
- OSF Saint Francis Medical Center, Peoria
- и още 3
A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.
Набиране на участнициФаза 2/3
- OSF Saint Francis Medical Center, Peoria
A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)
Набиране на участнициФаза 3
- Illinois Cancer Care ( Site 7000), Peoria
Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
Набиране на участнициФаза 3
- Illinois CancerCare-Peoria, Peoria
- Illinois CancerCare-Pekin, Pekin · на 9 мили
- Illinois CancerCare-Canton, Canton · на 25 мили
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
Набиране на участнициФаза 3
- Illinois Cancer Care, Peoria
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Набиране на участнициФаза 3
- Illinois Cancer Care, Peoria
- Illinois CancerCare- Pekin, Pekin · на 9 мили
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Набиране на участнициФаза 3
- Illinois CancerCare, P.C., Peoria
- Illinois CancerCare-Pekin, Pekin · на 9 мили
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Набиране на участнициФаза 2
- Illinois CancerCare, Peoria
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
Набиране на участнициФаза 3
- OSF Saint Francis Medical Center, Peoria
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
Набиране на участнициФаза 2
- Illinois CancerCare-Peoria, Peoria
- Methodist Medical Center of Illinois, Peoria
- Illinois CancerCare-Pekin, Pekin · на 9 мили
- и още 1
A Study of Gilteritinib in Adults With Advanced ALK-positive Non-small Cell Lung Cancer (NSCLC)
Набиране на участнициФаза 1
- OSF Health Care, Peoria
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
Набиране на участнициФаза 1
- OSF Saint Francis Medical Center, Peoria
A Study of Tolododekin Alfa (ANK-101) in Combination With an Anti-PD-1/PD-L1 Antibody in Participants With Advanced Non-Small Cell Lung Cancer
Набиране на участнициФаза 1
- OSF Healthcare System; Saint Francis Medical Center, Peoria
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
Набиране на участнициФаза 1
- St. Francis Medical Center (OSF Healthcare), Peoria
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Набиране на участнициФаза 2
- Illinois CancerCare-Peoria, Peoria
- Illinois CancerCare-Pekin, Pekin · на 9 мили
- Illinois CancerCare-Canton, Canton · на 25 мили
BBO-11818 in Adult Subjects With KRAS Mutant Cancer
Набиране на участнициФаза 1
- OSF Healthcare Cancer Institute, Peoria
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
Набиране на участнициФаза 2
- Illinois CancerCare-Peoria, Peoria
- Illinois CancerCare-Pekin, Pekin · на 9 мили
- Illinois CancerCare-Canton, Canton · на 25 мили
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Набиране на участнициФаза 2
- Illinois CancerCare-Peoria, Peoria
- Illinois CancerCare-Pekin, Pekin · на 9 мили
- Illinois CancerCare-Canton, Canton · на 25 мили
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Набиране на участнициФаза 2/3
- Illinois CancerCare-Peoria, Peoria
- Illinois CancerCare-Pekin, Pekin · на 9 мили
- Illinois CancerCare-Canton, Canton · на 25 мили
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Набиране на участнициНаблюдателно проучване
- Illinois CancerCare-Peoria, Peoria
- Illinois CancerCare-Pekin, Pekin · на 9 мили
- Illinois CancerCare-Canton, Canton · на 25 мили
Проучвания за Рак на белия дроб с недребноклетъчен тип в други градове
- Houston, TX145 проучвания
- New York City, NY120 проучвания
- Arlington, VA104 проучвания
- Nashville, TN97 проучвания
- Boston, MA90 проучвания
- Los Angeles, CA87 проучвания
- St. Louis, MO73 проучвания
- Chicago, IL61 проучвания
- Baltimore, MD60 проучвания
- San Antonio, TX59 проучвания
- Columbus, OH56 проучвания
- Washington, DC55 проучвания
Други проучвания в Peoria
- Рак на белия дроб12 проучвания
- Колоректален рак12 проучвания
- Рак на простатата9 проучвания
- Сърдечна недостатъчност8 проучвания
- Рак на гърдата8 проучвания
- Рак на яйчниците7 проучвания
- Плоскоклетъчен карцином на главата и шията7 проучвания
- Метастатичен рак7 проучвания
- Рак на панкреаса7 проучвания
- Рак (всички видове)7 проучвания
- Меланом6 проучвания
- Ендометриален рак6 проучвания
От ClinicalTrials.gov, данни към 5.10.2026 г.. Всяко проучване има свои критерии за участие; екипът на проучването определя кой може да се включи.